E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research 


The association between the elevated serum levels of cardiac Trop I and mortality in patients with and without pre-existing CAD in COVID-19 patients: A retrospective observational study

Narayanan Puthiya Veettil, Varun Raghavan Kallakudiyan, Anu Chandran Nirichan.

Abstract
Background: COVID-19 has appeared as a pandemic and public health issue at a universal level. First documented as a respiratory disease, COVID-19 has been found to interrelate with and disturb the cardiovascular system causing myocardial injury and also cardiac dysfunction. Initial documentation of cardiac pathology can play a substantial role in dropping the death rate. This study emphasizes on the relationship between the serum levels of cardiac Trop I and prognosis in patients with and without pre-existing CAD in COVID-19 patients.

Aims and Objectives: The first objective was to explore the association among the serum levels of cardiac Trop I and bad prognosis in patients with antiquity of CAD and without CAD. The secondary objective was to explore and understand whether increased Trop I is an appreciated prognostic indicator for COVID-19 patient antagonistic prognosis.

Materials and Methods: This was conducted as a retrospective observational study in which a whole of 45 patients admitted in COVID Hospital of Malabar Medical College and Research Center category C were studied. The medical record of the patients whose COVID-19 confirmation done by combined conclusions of reverse transcription PCR, symptoms, and chest X-ray was studies by the team.

Results: Mean age of the study participants was 59.3 ± 13.7. Every study participants had elevated Trop I levels with a median Trop I in study subjects being 397.9. There was a statistically significant elevation in Trop I levels in patients with CAD linked with non-CAD patients with a median IQR of 641.6 and P = 0.003 and there was a significant increase in Trop I levels in patients who expired related to patients who got discharged with a median IQR of 587.3 and P = 0.003.

Conclusion: From this study, we accomplish that rise in cardiac troponin-I level is connected with elevated mortality in patients with COVID-19. Hence, it can be used as significant biomarker of disease evolution, hospitalization, and worse prognosis in COVID-19 patients.

Key words: Coronary Artery Disease; COVID-19; Mortality; Troponin I


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Narayanan Puthiya Veettil
Articles by Varun Raghavan Kallakudiyan
Articles by Anu Chandran Nirichan
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Veettil NP, Kallakudiyan VR, Nirichan AC. The association between the elevated serum levels of cardiac Trop I and mortality in patients with and without pre-existing CAD in COVID-19 patients: A retrospective observational study. Natl J Physiol Pharm Pharmacol. 2023; 13(5): 1118-1121. doi:10.5455/njppp.2023.13.094632022026102022


Web Style

Veettil NP, Kallakudiyan VR, Nirichan AC. The association between the elevated serum levels of cardiac Trop I and mortality in patients with and without pre-existing CAD in COVID-19 patients: A retrospective observational study. https://www.njppp.com/?mno=117982 [Access: September 06, 2023]. doi:10.5455/njppp.2023.13.094632022026102022


AMA (American Medical Association) Style

Veettil NP, Kallakudiyan VR, Nirichan AC. The association between the elevated serum levels of cardiac Trop I and mortality in patients with and without pre-existing CAD in COVID-19 patients: A retrospective observational study. Natl J Physiol Pharm Pharmacol. 2023; 13(5): 1118-1121. doi:10.5455/njppp.2023.13.094632022026102022



Vancouver/ICMJE Style

Veettil NP, Kallakudiyan VR, Nirichan AC. The association between the elevated serum levels of cardiac Trop I and mortality in patients with and without pre-existing CAD in COVID-19 patients: A retrospective observational study. Natl J Physiol Pharm Pharmacol. (2023), [cited September 06, 2023]; 13(5): 1118-1121. doi:10.5455/njppp.2023.13.094632022026102022



Harvard Style

Veettil, N. P., Kallakudiyan, . V. R. & Nirichan, . A. C. (2023) The association between the elevated serum levels of cardiac Trop I and mortality in patients with and without pre-existing CAD in COVID-19 patients: A retrospective observational study. Natl J Physiol Pharm Pharmacol, 13 (5), 1118-1121. doi:10.5455/njppp.2023.13.094632022026102022



Turabian Style

Veettil, Narayanan Puthiya, Varun Raghavan Kallakudiyan, and Anu Chandran Nirichan. 2023. The association between the elevated serum levels of cardiac Trop I and mortality in patients with and without pre-existing CAD in COVID-19 patients: A retrospective observational study. National Journal of Physiology, Pharmacy and Pharmacology, 13 (5), 1118-1121. doi:10.5455/njppp.2023.13.094632022026102022



Chicago Style

Veettil, Narayanan Puthiya, Varun Raghavan Kallakudiyan, and Anu Chandran Nirichan. "The association between the elevated serum levels of cardiac Trop I and mortality in patients with and without pre-existing CAD in COVID-19 patients: A retrospective observational study." National Journal of Physiology, Pharmacy and Pharmacology 13 (2023), 1118-1121. doi:10.5455/njppp.2023.13.094632022026102022



MLA (The Modern Language Association) Style

Veettil, Narayanan Puthiya, Varun Raghavan Kallakudiyan, and Anu Chandran Nirichan. "The association between the elevated serum levels of cardiac Trop I and mortality in patients with and without pre-existing CAD in COVID-19 patients: A retrospective observational study." National Journal of Physiology, Pharmacy and Pharmacology 13.5 (2023), 1118-1121. Print. doi:10.5455/njppp.2023.13.094632022026102022



APA (American Psychological Association) Style

Veettil, N. P., Kallakudiyan, . V. R. & Nirichan, . A. C. (2023) The association between the elevated serum levels of cardiac Trop I and mortality in patients with and without pre-existing CAD in COVID-19 patients: A retrospective observational study. National Journal of Physiology, Pharmacy and Pharmacology, 13 (5), 1118-1121. doi:10.5455/njppp.2023.13.094632022026102022